Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
| Autor: | McElvaney, Noel G a, *, Burdon, Jonathan b, Holmes, Mark c, Glanville, Allan d, Wark, Peter A B e, Thompson, Philip J f, Hernandez, Paul g, Chlumsky, Jan h, Teschler, Helmut i, Ficker, Joachim H j, v, Seersholm, Niels k, Altraja, Alan l, Mäkitaro, Riitta m, Chorostowska-Wynimko, Joanna n, Sanak, Marek o, Stoicescu, Paul I p, Piitulainen, Eeva q, Vit, Oliver r, Wencker, Marion s, Tortorici, Michael A t, Fries, Michael t, Edelman, Jonathan M t, Chapman, Kenneth R u |
|---|---|
| Zdroj: | In The Lancet Respiratory Medicine January 2017 5(1):51-60 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|